Natixis’s Cardlytics CDLX Stock Holding History

Natixis’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,460	Closed	-$226K	–	1050
2025 Q1	$226K	Hold	12,460	–	–	﹤0.01%	726
2024 Q4	$462K	Buy	+12,460	New	+$477K	﹤0.01%	719

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Natixis's CDLX Position: Q2 2025 in Review

Natixis sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 12,460 shares — an estimated $226K sold.

Natixis first reported a position in CDLX in Q4 2024 and held it in 2 quarters. The position peaked at $462K in Q4 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

Natixis reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
Natixis sold 12,460 Cardlytics shares in Q2 2025, an estimated $226K.
Natixis first reported a position in Cardlytics in Q4 2024 and held it in 2 quarters.
Natixis's Cardlytics position peaked at $462K in Q4 2024.
89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Natixis's 13F filing for Q2 2025, filed 13 Aug 2025.